BlackRock MuniVest Fund II
Change company Symbol lookup
Select an option...
MVT BlackRock MuniVest Fund II
T AT&T Inc
TWO Two Harbors Investment Corp
PTIE Pain Therapeutics Inc
NGL NGL Energy Partners LP
AMID American Midstream Partners LP
SPH Suburban Propane Partners LP
SGU Star Group LP
FGP Ferrellgas Partners LP
PFE Pfizer Inc

Company profile

BlackRock MuniVest Fund II, Inc. is a non-diversified closed-end management investment company. The Fund's investment objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. The Fund seeks to achieve its investment objective by investing approximately 80% of its assets in municipal bonds exempt from federal income taxes (except that the interest may be subject to the federal alternative minimum tax). The Fund invests over 75% of its assets in municipal bonds rated investment grade and invests primarily in long-term municipal bonds with a maturity of approximately 10 years at the time of investment. The Fund may invest directly in such securities or synthetically through the use of derivatives. It invests in various sectors, such as transportation, corporate, education, housing, state and health. BlackRock Advisors, LLC is the Fund's investment manager.

Day's Change
-0.10 (-0.71%)
B/A Size
Day's High
Day's Low

Today's volume of 19,296 shares is on pace to be much lighter than MVT's 10-day average volume of 58,195 shares.


Pot stocks rally toward sixth-straight gain ahead of midterm elections

12:35 pm ET November 6, 2018 (MarketWatch)

Shares of cannabis companies were broadly higher Tuesday, with the sector headed for a sixth-straight gain, as investors wait for election results to see if two more states--Michigan and North Dakota ( make recreational marijuana legal. The ETFMG Alternative Harvest ETF (MJ) ran up 4.0%, with 25 of 37 components trading higher. It has gained 19% amid a six-session win streak. The Horizons Marijuana Life Sciences ETF hiked up 4.9%. Among the sector's more-active stocks, Aurora Cannabis Inc. surged 3.3%, Canopy Growth Corp. (WEED.T) rose 8.8%, Cronos Group Inc. (CRON.T) soared 13% and Tilray Inc. rallied 5.6%. Shares of GW Pharmaceuticals PLC (GWPH) slipped 0.8%, although Morgan Stanley reiterated its overweight rating and price target of $227, which was 59% above current levels. Analyst David Lebowitz expects strong demand for Epidiolex, the first cannabis-based drug on the market approved by the Food and Drug Administration, with sales expected to be recorded starting in the fourth quarter. The ETFMG ETF has rallied 30% over the past three months, while the S&P 500 has lost 3.5%.

-Tomi Kilgore; 415-439-6400;

(END) Dow Jones Newswires

November 06, 2018 12:35 ET (17:35 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.